Amanote Research
Register
Sign In
Editorial: Grey Zone, a New Area of Interest in Chronic Hepatitis B
Alimentary Pharmacology and Therapeutics
- United Kingdom
doi 10.1111/apt.14644
Full Text
Open PDF
Abstract
Available in
full text
Categories
Hepatology
Pharmacology
Gastroenterology
Date
May 17, 2018
Authors
E. Ridruejo
Publisher
Wiley
Related search
New Therapies for Chronic Hepatitis B
Liver International
Hepatology
Editorial: Can Hepatitis B Core-Related Antigen Be the New Biomarker for Hepatocellular Carcinoma in Nucleoside Analogue-Treated Chronic Hepatitis B?
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Editorial: Can Hepatitis B Core-Related Antigen Be the New Biomarker for Hepatocellular Carcinoma in Nucleoside Analogue-Treated Chronic Hepatitis B? Author’s Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Chronic Hepatitis B
Acta Medica Medianae
Chronic Hepatitis B
Hepatology
Medicine
Hepatology
Searching for Chronic Hepatitis B Patients in a Low Prevalence Area – Role of Racial Origin
BMC Family Practice
Family Practice
Precore Mutant of Hepatitis B Virus Prevails in Acute and Chronic Infections in an Area in Which Hepatitis B Is Endemic.
Journal of Clinical Microbiology
Microbiology
Historical Treatment of Chronic Hepatitis B and Chronic Hepatitis C.
Gut
Gastroenterology
Editorial: The Durability of Seroconversion of Hepatitis B E Antigen in the Treatment of Chronic Hepatitis B With PEG-interferon Alfa-2a
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
